March 2026
The global vitamin K2 market size reached at USD 292.62 million in 2025 and is anticipated to increase from USD 332.56 million in 2026 to an estimated USD 1,051.96 million by 2035, witnessing a CAGR of 13.65% during the forecast period from 2026 to 2035. The growth in MK-7 and the aging worldwide population drives market growth.

| Study Coverage | Details |
| Growth Rate from 2026 to 2035 | CAGR of 13.65% |
| Market Size in 2026 | USD 332.56 Million |
| Market Size in 2027 | USD 377.96 Million |
| Market Size by 2035 | USD 1,051.96 Million |
| Largest Market | North America |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Vitamin K2 is a key nutrient that is present in fermented and animal products. It prevents calcification of vessels and enhances the density of bones. It is present in food sources like Swiss cheese, egg yolks, kefir, fatty fish, natto, chicken liver, bacon, and many others. It offers benefits like lowering heart attack risks, increasing dental health, and preventing osteoporosis. It is categorized into two forms, such as MK-7 and MK-4. The applications of vitamin K2 are calcification prevention, neuroprotection, heart health management, and blood sugar management. Vitamin K2 is safe for daily intake, and it boosts proper brain functioning.
The vitamin K2 market growth is driven by the increased awareness about calcium metabolism, the rise in osteoporosis in aged individuals, focus on bone mineralization, growth in fortified beverages, growth in synergistic formulation, development of non-synthetic supplements, popularity of K2-rich foods, and the rise in arterial stiffness.
The vitamin K2 market is experiencing key technological shifts driven by demand for sustainable production, enhanced stability, and advanced fermentation. The innovations like advanced encapsulation, matrix technology, metabolic engineering, and data-driven personalization drive demand for stability and customized supplements. The major AI innovations fuel demand for personalised nutrition and enhanced experience for consumers.
AI optimizes the bioavailability of vitamin K2 and improves the quality control. AI supports product selection and analyzes consumer health trends. AI provides effective marketing strategies and analyzes novel applications. AI easily develops bioavailable formulations and supports cost-effective production. AI enhances the consumers engagement and lowers product stockouts. Overall, AI helps in enhancing the final quality of vitamin K2 products.
Raw Material Procurement
Processing and Preservation
Quality Testing and Certifications
Why North America Dominated the Vitamin K2 Market?
North America dominated the vitamin K2 market in 2025. The need to prevent heart conditions and the expanding fortified foods increase the adoption of vitamin K2. The huge investment in natural K2 and the rising osteoporosis cases boost market expansion. The mature dietary supplement industry and the increased awareness of bone health increases production of vitamin K2. The growth in the development of plant-based vitamin K2 drives the market growth.
North America Vitamin K2 Market Size 2025 to 2035
The North America vitamin K2 market size was calculated at USD 105.34 million in 2025 with projections indicating a rise from USD 119.72 million in 2026 to approximately USD 383.97 million by 2035, expanding at a CAGR of 13.81% throughout the forecast period from 2026 to 2035.

Vitamin K2 Revolutionizing Heart and Bone Health in the United States
The United States is expanding in the market. The increased awareness of cardiovascular wellness and the strong growth in e-commerce increase demand for vitamin K2. The management of bone health problems and the need for calcium management increases the adoption of vitamin K2. The well-established MK-7 industry helps market expansion. The presence of companies like Kemin Industries and DSM Nutritional Products supports market growth.
U.S. Vitamin K2 Market Size 2025 to 2035
The U.S. vitamin K2 market size was valued at USD 79.01 billion in 2025 and is expected to grow steadily from USD 89.79 billion in 2026 to reach nearly USD 289.89 billion by 2035, with a CAGR of 13.88% during the forecast period from 2026 to 2035.

Asia Pacific Vitamin K2 Market Trends
Asia Pacific is experiencing the fastest growth in the market during the forecast period. The prevalence of age-related conditions and the focus on halting arterial calcification increase demand for vitamin K2. The rising acceptance of fermented foods and the higher priority on wellness increases adoption of vitamin K2. The expansion of Amazon and the ongoing product innovation require vitamin K2. The well-established vitamin K2 production facility drives market growth.

From Tradition to Nutrients: Japan’s Role in Vitamin K2
Japan is consistently growing in the market. The need to enhance arterial health and the higher consumption of natto increases adoption of vitamin K2. The awareness of vascular calcification and the surge in vitamin-enriched foods increases demand for vitamin K2. The highest adoption rate of MK-7 and major players like J-Oil Mills support the market growth.
Vitamin K2 Market Share, By Product, 2025 (%)
| Segments | Shares (%) |
| MK-7 | 70% |
| MK-4 | 30% |
Why MK-7 Segment Dominates the Vitamin K2 Market?
The MK-7 segment dominated the vitamin K2 market in 2025. The focus on stimulating osteocalcin and the rise in daily supplementation increase demand for MK-7. The popularity of non-synthetic products and the rise in fermented sourcing increases adoption of MK-7. The superior pharmacokinetics, once-daily dosing, superior bioavailability, and long-lasting effect of MK-7 drive market growth.
The MK-4 segment is the fastest-growing in the market during the forecast period
The growing diseases related to calcium metabolism and the need for activating protein increase demand for MK-4. The focus on treating bone issues and the growing mineral density increases the adoption of MK-4. The rapid bioavailability, tissue specificity, and pharmaceutical stability of MK-4 support market growth.
Vitamin K2 Market Share, By Dosage Form, 2025 (%)
| Segments | Shares (%) |
| Capsules/Tablets | 60% |
| Softgels | 20% |
| Liquid | 12% |
| Others | 8% |
How did the Capsules/Tablets Segment hold the Largest Share in the Vitamin K2 Market?
The capsules/tablets segment held the largest revenue share in the vitamin K2 market in 2025. The need to target bone health and the aging population increases the consumption of capsules. The manufacturing ease and formulation flexibility of tablets help market expansion. The superior protection, nutrient efficacy, portability, standardized dosage, and lower cost of capsules/tablets drive market growth.
The softgel segment is experiencing the fastest growth in the market during the forecast period
The increased knowledge about arterial health and the rise in premium supplementation increase the consumption of softgels. The optimal formulation, enhanced absorption, superior protection, high-quality, and easy swallowing of softgel support the market growth.
Vitamin K2 Market Share, By Source, 2025 (%)
| Segments | Shares (%) |
| Natural | 30% |
| Synthetic | 70% |
What made the Synthetic Segment Dominate the Vitamin K2 Market?
The synthetic segment dominated the vitamin K2 market in 2025. The production of high-purity products and the strong focus on filling capsules increases adoption of synthetic vitamin K2. The strong focus on therapeutic applications and expanded pharmaceutical demand increases the adoption of synthetic vitamin K2. The production efficiency, scalability, and manufacturing consistency of synthetic vitamin K2 drive market growth.
The natural segment is the fastest-growing in the market during the forecast period
The preference for clean ingredients and the focus on regulating calcium increases demand for natural vitamin K2. The growing number of people moving towards vegan diets and adults preference for organic supplements increases the adoption of natural vitamin K2. The strong regulatory support and high bioavailability of natural vitamin K2 support market growth.
How did the Bone Health Segment hold the Largest Share in the Vitamin K2 Market?
The bone health segment held the largest revenue share in the market in 2025. The reduction in bone density of bones and the focus on preserving bone quality increase demand for vitamin K2. The growing fracture risks and the awareness of skeletal health increases adoption of vitamin K2. The focus on preventing osteoclast formation and the adoption of joint care items drive the overall market growth.
The heart health segment is experiencing the fastest growth in the market during the forecast period
The focus on enhancing arterial elasticity and the awareness about cardiovascular risks increases demand for vitamin K2. The growth in arterial stiffness issues and focus on improving heart health requires vitamin K2. The proper heart functioning requires vitamin K2, which supports the overall market growth.
Which Application Dominated the Vitamin K2 Market?
The health supplements segment dominated the vitamin K2 market in 2025. The prevention of osteoporosis in postmenopausal women and the focus on avoiding reactive medicine increases the consumption of vitamin K2. The westernization of diet and aging demographics requires health supplements like vitamin K2. The integration of vitamin K2 with other nutrients drives market growth.
The functional foods & beverages segment is the fastest-growing in the market during the forecast period
The focus on maintaining bone strength and daily nutrient consumption increases the consumption of vitamin K2-integrated functional food. The rise in fortifying and awareness about the importance of nutrition increases the consumption of functional beverages that have vitamin K. The scientific awareness and convenience of vitamin K-based functional products support market growth.
AstaReal AB
Kappa Bioscience & Partners
By Product
By Dosage Form
By Source
By Indication
By Application
By Region
March 2026
March 2026
March 2026
March 2026